Filing Details

Accession Number:
0000950103-20-020542
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-10-23 19:11:32
Reporting Period:
2020-10-20
Accepted Time:
2020-10-23 19:11:32
Original Submission Date:
2020-10-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802768 Royalty Pharma Plc RPRX () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016835 B Rory Riggs C/O Royalty Pharma Plc
110 E. 59Th Street
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Ordinary Shares Disposition 2020-10-20 463,200 $42.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. On October 22, 2020, the Reporting Person filed a Form 4 reporting this sale. This amendment is being filed to report that this sale was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 15,000 Class A Ordinary Shares, with the purchase of Class A Ordinary Shares by the Spouse of the Reporting Person on June 18, 2020. The Reporting Person has voluntarily disgorged to the Issuer the full amount of the resulting statutory "profit" calculated pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.